103 related articles for article (PubMed ID: 8998822)
1. [Importance of vitamin D in prostatic carcinoma].
Wilczek H; Vachalovský
Cas Lek Cesk; 1996 Nov; 135(22):716-8. PubMed ID: 8998822
[TBL] [Abstract][Full Text] [Related]
2. [Monitoring plasma levels of vitamin D metabolites in simvastatin (Zocor) therapy in patients with familial hypercholesterolemia].
Wilczek H; Sobra J; Ceska R; Justová V; Jůzová Z; Procházková R; Kvasilová M
Cas Lek Cesk; 1994 Dec; 133(23):727-9. PubMed ID: 7834670
[TBL] [Abstract][Full Text] [Related]
3. [What do we know about the significance of vitamin D in Paget's disease of the bone?].
Wilczek H; Stĕpán J; Justová V
Cas Lek Cesk; 1995 Dec; 134(24):785-7. PubMed ID: 8599821
[TBL] [Abstract][Full Text] [Related]
4. The promiscuous receptor.
Newsom-Davis TE; Kenny LM; Ngan S; King J; Waxman J
BJU Int; 2009 Nov; 104(9):1204-7. PubMed ID: 19426197
[TBL] [Abstract][Full Text] [Related]
5. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
6. Vitamin D receptor polymorphisms, circulating vitamin D metabolites, and risk of prostate cancer in United States physicians.
Ma J; Stampfer MJ; Gann PH; Hough HL; Giovannucci E; Kelsey KT; Hennekens CH; Hunter DJ
Cancer Epidemiol Biomarkers Prev; 1998 May; 7(5):385-90. PubMed ID: 9610787
[TBL] [Abstract][Full Text] [Related]
7. Vitamin D and the epidemiology of prostate cancer.
Schwartz GG
Semin Dial; 2005; 18(4):276-89. PubMed ID: 16076349
[TBL] [Abstract][Full Text] [Related]
8. Vitamin D status, seasonal variations, parathyroid adenoma weight and bone mineral density in primary hyperparathyroidism.
Moosgaard B; Vestergaard P; Heickendorff L; Melsen F; Christiansen P; Mosekilde L
Clin Endocrinol (Oxf); 2005 Nov; 63(5):506-13. PubMed ID: 16268801
[TBL] [Abstract][Full Text] [Related]
9. Phase I-II trial evaluating combined intensity-modulated radiotherapy and in situ gene therapy with or without hormonal therapy in treatment of prostate cancer-interim report on PSA response and biopsy data.
Teh BS; Ayala G; Aguilar L; Mai WY; Timme TL; Vlachaki MT; Miles B; Kadmon D; Wheeler T; Caillouet J; Davis M; Carpenter LS; Lu HH; Chiu JK; Woo SY; Thompson T; Aguilar-Cordova E; Butler EB
Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1520-9. PubMed ID: 15050332
[TBL] [Abstract][Full Text] [Related]
10. Correspondence re: E. H. Corder et al., Vitamin D and prostate cancer: a prediagnostic study with stored sera. Cancer Epidemiol., Biomarkers & Prev., 2: 467-472, 1993.
Schwartz GG
Cancer Epidemiol Biomarkers Prev; 1994 Mar; 3(2):183-4. PubMed ID: 8049642
[No Abstract] [Full Text] [Related]
11. Interaction of factors related to the metabolic syndrome and vitamin D on risk of prostate cancer.
Tuohimaa P; Tenkanen L; Syvälä H; Lumme S; Hakulinen T; Dillner J; Hakama M
Cancer Epidemiol Biomarkers Prev; 2007 Feb; 16(2):302-7. PubMed ID: 17301263
[TBL] [Abstract][Full Text] [Related]
12. Serum levels of prostate-specific antigen and vitamin D in peritoneal dialysis patients.
Passadakis P; Ersoy F; Tam P; Memmos D; Siamopoulos K; Ozener C; Akçiçek F; Camsari T; Ates K; Ataman R; Vlachojannis J; Dombros N; Utas C; Akpolat T; Bozfakioglu S; Wu GG; Karayaylali I; Arinsoy T; Stathakis C; Yavuz M; Tsakiris D; Dimitriades A; Yilmaz ME; Gültekin M; Karayalçin B; Challa A; Polat N; Oreopoulos DG
Adv Perit Dial; 2004; 20():203-8. PubMed ID: 15384827
[TBL] [Abstract][Full Text] [Related]
13. Is vitamin D deficiency a risk factor for prostate cancer? (Hypothesis).
Schwartz GG; Hulka BS
Anticancer Res; 1990; 10(5A):1307-11. PubMed ID: 2241107
[TBL] [Abstract][Full Text] [Related]
14. High-dose weekly oral calcitriol in patients with a rising PSA after prostatectomy or radiation for prostate carcinoma.
Beer TM; Lemmon D; Lowe BA; Henner WD
Cancer; 2003 Mar; 97(5):1217-24. PubMed ID: 12599228
[TBL] [Abstract][Full Text] [Related]
15. Seasonal and geographical variations in lung cancer prognosis in Norway. Does Vitamin D from the sun play a role?
Porojnicu AC; Robsahm TE; Dahlback A; Berg JP; Christiani D; Bruland OS; Moan J
Lung Cancer; 2007 Mar; 55(3):263-70. PubMed ID: 17207891
[TBL] [Abstract][Full Text] [Related]
16. Calcium intake and vitamin D metabolism and action, in healthy conditions and in prostate cancer.
Bonjour JP; Chevalley T; Fardellone P
Br J Nutr; 2007 Apr; 97(4):611-6. PubMed ID: 17349071
[TBL] [Abstract][Full Text] [Related]
17. Calcium, dairy products, and the risk of prostate cancer.
Tavani A; Gallus S; Franceschi S; La Vecchia C
Prostate; 2001 Jul; 48(2):118-21. PubMed ID: 11433421
[TBL] [Abstract][Full Text] [Related]
18. Prostate cancer progression in the presence of undetectable or low serum prostate-specific antigen level.
Leibovici D; Spiess PE; Agarwal PK; Tu SM; Pettaway CA; Hitzhusen K; Millikan RE; Pisters LL
Cancer; 2007 Jan; 109(2):198-204. PubMed ID: 17171704
[TBL] [Abstract][Full Text] [Related]
19. Risk of prostate cancer in a randomized clinical trial of calcium supplementation.
Baron JA; Beach M; Wallace K; Grau MV; Sandler RS; Mandel JS; Heber D; Greenberg ER
Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):586-9. PubMed ID: 15767334
[TBL] [Abstract][Full Text] [Related]
20. Vitamin D and the elderly.
Mosekilde L
Clin Endocrinol (Oxf); 2005 Mar; 62(3):265-81. PubMed ID: 15730407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
